Theravance Biopharma (TBPH) PT Raised to $15 at TD Cowen

March 23, 2026 9:12 AM

TD Cowen analyst Marc Frahm raised the price target on Theravance Biopharma (NASDAQ: TBPH) to $15.00 (from $13.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found